Select Biotechnology Portfolio CADL Holdings History
Select Biotechnology Portfolio's Candel Therapeutics Inc Holding Summary
As of 2025-02-28, Select Biotechnology Portfolio held 5.54 Mil shares of Candel Therapeutics Inc(CADL), totaling $49.77 Mil. This investment constitutes 1.18% of their stock portfolio, and Select Biotechnology Portfolio now holds 11.07% of the outstanding Candel Therapeutics Inc(CADL) stock.
The initial trade took place in 2021Q4. And since then Select Biotechnology Portfolio has made 1 purchases of CADL, at an average price of $8.50, for a total of 8.00 Mil shares. In addition, there have been 11 sales at an average price of $3.83 for 2.45 Mil shares. Based on historical transaction data and CADL's current price of $6.85, Select Biotechnology Portfolio's estimated gain on his CADL holdings is $-20.62 Mil, reflecting a -30.34% gain to date.
Select Biotechnology Portfolio CADL ($6.85) Holding Chart
Select Biotechnology Portfolio CADL ($6.85) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
